Skip to main content
All lobbying filings

NORTH SOUTH GOVERNMENT STRATEGIES, FKA JDM PUBLIC STRATEGIES, LLC

Lobbying for MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMER · Distribution

 Filing 1st Quarter - Report
1st Quarter (Jan 1 - Mar 31) 2026 · Texas · House · Senate · $30,000.00 income · posted Apr 20, 2026

Official filing document

 Bills named in this filing 11
  • HR 3521
    Clinical Trial Modernization Act
  • HR 1
    An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
  • HR 2484
    Seniors’ Access to Critical Medications Act of 2025
  • HR 879
    Medicare Patient Access and Practice Stabilization Act of 2025
  • HR 2120
    ROCR Value Based Program Act
  • S 1816
    Improving Seniors’ Timely Access to Care Act of 2025
  • HR 3514
    Improving Seniors’ Timely Access to Care Act of 2025
  • HR 4299
    Protecting Patient Access to Cancer and Complex Therapies Act
  • HR 3164
    Ensuring Community Access to Pharmacist Services Act
  • HR 2444
    Promoting Resilient Supply Chains Act of 2025
  • S 257
    Promoting Resilient Supply Chains Act of 2025
 Lobbying activity 4
Health Issues

H.R. 3521, Clinical Trial Modernization Act; H.R. 1, One Big Beautiful Bill (Definition clarity around distributors); Drug Shortages; Safe Step Act (not reintroduced in 119th) (Support establishing an exception to medication step-therapy protocol in specified cases).

Medicare/Medicaid

H.R. 2484, Seniors Access to Critical Medications Act of 2025 (Support: Allows medically integrated physician dispensing flexibilities); H.R. 879, Medicare Patient Access and Practice Stabilization Act of 2025 (Support: Increases provider reimbursement in the Physician Fee Schedule); H.R. 2120, ROCR Value Based Program Act (Support: Modifies Medicare payment system for radiation oncology services); S. 1816 H.R. 3514, Improving Seniors' Timely Access to Care Act of 2025 (Support: Streamlines prior authorization process); Medicare Physician Payment; Site Neutral Payment Reform; CY2026 Medicare Physician Fee Schedule Proposed Rule; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act of 2025 (Support: Provide for a rebate by manufacturers for selected drugs and biological products subject to maximum fair price negotiation); PBM Transparency; Emergency Preparedness.

Pharmacy

H.R. 3164, Ensuring Community Access to Pharmacist Services Act

Manufacturing

H.R. 2444, Promoting Resilient Supply Chains Act; S. 257, Promoting Resilient Supply Chains

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem